Serveur d'exploration H2N2 - Exploration (Accueil)

Index « Mesh.i » - entrée « Vaccination »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Uveitis, Anterior < Vaccination < Vaccines, Attenuated  Facettes :

List of bibliographic references indexed by Vaccination

Number of relevant bibliographic references: 36.
Ident.Authors (with country if any)Title
000160 (2018) Daniil A. Korenkov [Russie] ; Karen L. Laurie [Australie] ; Patrick C. Reading [Australie] ; Louise A. Carolan [Australie] ; Kok Fei Chan [Australie] ; Irina I. Isakova-Sivak [Russie] ; Tatiana A. Smolonogina [Russie] ; Kanta Subbarao [Australie] ; Ian G. Barr [Australie] ; Julie Villanueva [États-Unis] ; Svetlana Shcherbik [États-Unis] ; Tatiana Bousse [États-Unis] ; Larisa G. Rudenko [Russie]Safety, immunogenicity and protection of A(H3N2) live attenuated influenza vaccines containing wild-type nucleoprotein in a ferret model.
000220 (2018) Guo Luo ; Aditya Ambati ; Ling Lin ; Mélodie Bonvalet ; Markku Partinen [Finlande] ; Xuhuai Ji ; Holden Terry Maecker ; Emmanuel Jean-Marie MignotAutoimmunity to hypocretin and molecular mimicry to flu in type 1 narcolepsy
000531 (2015) Milton Thomas [États-Unis] ; Zhao Wang [États-Unis] ; Chithra C. Sreenivasan [États-Unis] ; Ben M. Hause [États-Unis] ; Gourapura J Renukaradhya [États-Unis] ; Feng Li [États-Unis] ; David H. Francis [États-Unis] ; Radhey S. Kaushik [États-Unis] ; Mahesh Khatri [États-Unis]Poly I:C adjuvanted inactivated swine influenza vaccine induces heterologous protective immunity in pigs.
000602 (2015) Mariana Baz [États-Unis] ; Myeisha Paskel [États-Unis] ; Yumiko Matsuoka [États-Unis] ; James R. Zengel [États-Unis] ; Xing Cheng [États-Unis] ; John J. Treanor [États-Unis] ; Hong Jin [États-Unis] ; Kanta Subbarao [Indonésie]A Single Dose of an Avian H3N8 Influenza Virus Vaccine Is Highly Immunogenic and Efficacious against a Recently Emerged Seal Influenza Virus in Mice and Ferrets.
000691 (2014) Gerald Aichinger [Autriche] ; Barbara Grohmann-Izay [Autriche] ; Maikel V. W. Van Der Velden [Autriche] ; Sandor Fritsch [Autriche] ; Manuela Koska [Autriche] ; Daniel Portsmouth [Autriche] ; Mary Kate Hart [États-Unis] ; Wael El-Amin [États-Unis] ; Otfried Kistner [Autriche] ; P. Noel Barrett [Autriche]Phase I/II Randomized Double-Blind Study of the Safety and Immunogenicity of a Nonadjuvanted Vero Cell Culture-Derived Whole-Virus H9N2 Influenza Vaccine in Healthy Adults
000741 (2014) Irina Isakova-Sivak [États-Unis, Russie] ; Li-Mei Chen [États-Unis] ; Melissa Bourgeois [États-Unis] ; Yumiko Matsuoka [États-Unis] ; J. Theo M. Voeten [Pays-Bas] ; Jacco G. M. Heldens [Pays-Bas] ; Han Van Den Bosch [Pays-Bas] ; Alexander Klimov [États-Unis] ; Larisa Rudenko [Russie] ; Nancy J. Cox [États-Unis] ; Ruben O. Donis [États-Unis]Characterization of Reverse Genetics-Derived Cold-Adapted Master Donor Virus A/Leningrad/134/17/57 (H2N2) and Reassortants with H5N1 Surface Genes in a Mouse Model
000804 (2013) Wilfried Witte[Pandemic without drama. Influenza vaccination and Asian flu in Germany].
000A85 (2012) Kawsar R. Talaat ; Ruth A. Karron ; Philana H. Liang ; Bridget A. Mcmahon ; Catherine J. Luke ; Bhagvanji Thumar ; Grace L. Chen ; Ji-Young Min ; Elaine W. Lamirande ; Hong Jin ; Kathy L. Coelingh ; George W. Kemble ; Kanta SubbaraoAn open‐label phase I trial of a live attenuated H2N2 influenza virus vaccine in healthy adults
000B97 (2011) Guus F. Rimmelzwaan [Pays-Bas] ; Rogier Bodewes ; Albert D M E. OsterhausVaccination strategies to protect children against seasonal and pandemic influenza.
000C35 (2011) T V Chirkova [Russie] ; A N Naykhin ; G D Petukhova ; D A Korenkov ; S A Donina ; A N Mironov ; L G RudenkoMemory T-cell immune response in healthy young adults vaccinated with live attenuated influenza A (H5N2) vaccine.
000C50 (2011) Penghui Yang [République populaire de Chine] ; Yueqiang Duan ; Cheng Wang ; Li Xing ; Xiao Gao ; Chong Tang ; Deyan Luo ; Zhongpeng Zhao ; Weihong Jia ; Daxin Peng ; Xiufan Liu ; Xiliang WangImmunogenicity and protective efficacy of a live attenuated vaccine against the 2009 pandemic A H1N1 in mice and ferrets.
000D08 (2011) Gary J. Nabel [États-Unis] ; Chih-Jen Wei [États-Unis] ; Julie E. Ledgerwood [États-Unis]Vaccinate for the next H2N2 pandemic now
000D93 (2010) N A Mazurkova ; N N Ryndiuk ; L N Shishkina ; V A Ternovo ; Iu V. Tumanov ; L E Bulychev ; M O Skarnovich ; A S Kabanov ; S G Panchenko ; R P Ale Nikov ; T N Il'Ina ; V I Kuzubov ; S Ia Mel'Nikov ; A N Mironov ; S A Korovkin ; A N Sergeev ; I G Drozdov[Results of clinical trials on reactogenicity, safety, and immunogenicity of influenza allantoic intranasal live vaccine "Ultragrivac" (type A/H5N2)].
000E67 (2010) Chih-Jen Wei [États-Unis] ; Jeffrey C. Boyington ; Patrick M. Mctamney ; Wing-Pui Kong ; Melissa B. Pearce ; Ling Xu ; Hanne Andersen ; Srinivas Rao ; Terrence M. Tumpey ; Zhi-Yong Yang ; Gary J. NabelInduction of broadly neutralizing H1N1 influenza antibodies by vaccination.
001087 (2009) Shufang Fan [République populaire de Chine] ; Yuwei Gao ; Kyoko Shinya ; Chris Kafai Li ; Yanbing Li ; Jianzhong Shi ; Yongping Jiang ; Yongbing Suo ; Tiegang Tong ; Gongxun Zhong ; Jiasheng Song ; Ying Zhang ; Guobin Tian ; Yuntao Guan ; Xiao-Ning Xu ; Zhigao Bu ; Yoshihiro Kawaoka [États-Unis] ; Hualan ChenImmunogenicity and protective efficacy of a live attenuated H5N1 vaccine in nonhuman primates.
001243 (2008) R J Green [Afrique du Sud] ; C. Feldman ; B. Schoub ; G A Richards ; S A Madhi ; H J Zar ; U. Lalloo ; K. Klugman ; D. Phillips ; N A Cameron ; R R EggersInfluenza guideline for South Africa--update 2008.
001653 (2004) Thomas Palker [États-Unis] ; Irina Kiseleva ; Kimberly Johnston ; Qin Su ; Timothy Toner ; Christopher Szymkowiak ; Wan-Sang Kwan ; Boris Rubin ; Luba Petrukhin ; Joan Wlochowski ; Juanita Monteiro ; Nikolai Kraiouchkine ; Daniel Distefano ; Larisa Rudenko ; Alan Shaw ; Rima YouilProtective efficacy of intranasal cold-adapted influenza A/New Caledonia/20/99 (H1N1) vaccines comprised of egg- or cell culture-derived reassortants.
001B22 (1997) K. Hashigucci ; S. Tamura ; T. Kurata ; H. Kamiya ; T. Ishidate[Efficacy of nasal influenza vaccine combined with Escherichia coli heat-labile enterotoxin B subunit containing a trace amount of the holotoxin in healthy volunteers].
002128 (1990) I. N. Mbawuike ; H. R. Six ; T. R. Cate ; R. B. CouchVaccination with inactivated influenza A virus during pregnancy protects neonatal mice against lethal challenge by influenza A viruses representing three subtypes
002352 (1986) Tadao Sonoguchi [Japon] ; Mitsuo Sakoh [Japon] ; Nobuharu Kunita [Japon] ; Kiyoaki Satsuta [Japon] ; Hideo Noriki [Japon] ; Hideo Fukumi [Japon]Reinfection with Influenza A (H2N2, H3N2, and H1N1) Viruses in Soldiers and Students in Japan
002498 (1984) N. Yamane [Japon] ; Y. Nakamura [Japon] ; M. Yuki [Japon] ; T. Odagiri [Japon] ; N. Ishida [Japon]Serological evaluation of an influenza A virus cold-adapted reassortant live vaccine, CR-37 (H1N1), in Japanese adult volunteers
002567 (1983) M L Clements ; S. O'Donnell ; M M Levine ; R M Chanock ; B R MurphyDose response of A/Alaska/6/77 (H3N2) cold-adapted reassortant vaccine virus in adult volunteers: role of local antibody in resistance to infection with vaccine virus.
002709 (1981) Y Z Ghendon ; A I Klimov ; G I Alexandrova ; F I PolezhaevAnalysis of genome composition and reactogenicity of recombinants of cold-adapted and virulent virus strains.
002778 (1980) W H Barker ; J P MulloolyInfluenza vaccination of elderly persons. Reduction in pneumonia and influenza hospitalizations and deaths.
002A78 (1977) Gary R. Noble [Géorgie (pays), États-Unis] ; Harold S. Kaye [Géorgie (pays)] ; Alan P. Kendal [Géorgie (pays)] ; Walter R. Dowdle [Géorgie (pays)]Age-Related Heterologous Antibody Responses to Influenza Virus Vaccination
002B11 (1976) B. Dolezalová ; E. Tu Ková ; M. Stárek ; V. Vonka ; H. ZavadovaAbility of temperature-sensitive mutants of the recombinant influenza S/N (H2N1) virus to induce immunity to parental (H0N1 and H2N2) viruses.
002B64 (1975) E. Reichert ; R. MaulerEffect of neuraminidase on potency of inactivated influenza virus vaccines in mice.
002B99 (1974) M. Alexandrescu ; L. Handrache ; V. Moro Anu ; G. Vancea ; L. Ionescu ; A. ColevInfluenza viruses and lympho-macrophagic cells. I. In vitro interaction between influenza A2-59 virus (H2N2) and peritoneal macrophagic cells from normal or immunized mice and rats.
002D78 (????) Iu A. Desheva ; G V Danini ; E P Grigor'Eva ; S A Donina ; I V Kiseleva ; A R Rekstin ; L A Ermakova ; V K Natsina ; V M Nikolaeva ; N I Lonskaia ; G A El'Shina ; V G Zhavoronkov ; V P Drinevski ; M K Erofeeva ; A N Na Khin ; L G Rudenko[The investigation of the safety, genetic stability and immunogenicity of live influenza vaccine for adults in vaccination of 3-6 years old children].
002D79 (????) Iu A. Desheva ; Kh Lu ; A R Rekstin ; D M Kats ; L G Rudenko ; A I Klimov[The inoculative properties of cold-adapted reassortant A(H5N2) influenza strain during intranasal administration to mice].
002D80 (????) E Iu Boravleva ; N F Lomakina ; E A Kropotkina ; I A Rudneva ; S S Iamnikova ; L G Rudenko ; V V Drygin ; A S Gambarian[The generation and characteristics of reassortant influenza A virus with H5 hemagglutinin and other genes from the apathogenic virus H6N2].
002D84 (????) E P Grigor'Eva ; Iu A. Desheva ; S A Donina ; A N Na Khin ; A R Rekstin ; I B Barantseva ; E A Zavitkova ; T M Moskvicheva ; V G Zhavoronkov ; L G Rudenko[The comparative characteristics of the safety, immunogenic activity and prophylactic potency of the adult and children types of live influenza vaccine in schoolchildren aged 7-14 years].
002E11 (????) L A Stepanova ; A A Kovaleva ; M V Potapchuk ; A V Korotkov ; V V Kupriianov ; E A Blokhina ; R Iu Kotliarov ; L M Tsybalova[Immunogenicity of recombinant proteins including ectodomain of M2 influenza virus A].
002E24 (????) I V Kiseleva ; A I Klimov ; E P Grigor'Eva ; N V Larionova ; G I Aleksandrova ; L G Rudenko[Genetic and phenotypic analysis of heterogeneous population of a cold-adapted donor of the A/Leningrad/134/17/57 (H2N2) attenuation and of the donor-based reassortant influenza vaccine strains].
002E26 (????) T A Smolonogina ; Iu A. Desheva ; A R Rekstin ; A N Mironov ; L G Rudenko[Evaluation of the anti-neuraminidase antibodies in clinical trials of the live influenza vaccine of the A(H5N2) subtype].
002E38 (????) O S Kashirina ; M I Chernikova ; Yu M. Vasiliev[COMPARATIVE STUDY OF IMMUNOGENICITY AND PROTECTIVE EFFECT OF LIVE COLD-ADAPTED AND INACTIVATED VACCINES AGAINST TYPE A INFLUENZA].

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/H2N2V1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i -k "Vaccination" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i  \
                -Sk "Vaccination" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    H2N2V1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Vaccination
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 14 19:59:40 2020. Site generation: Thu Mar 25 15:38:26 2021